131 related articles for article (PubMed ID: 9683834)
1. Detection of HPV and ras gene mutations in cervical smears from female genital lesions.
Dokianakis DN; Sourvinos G; Sakkas S; Athanasiadou E; Spandidos DA
Oncol Rep; 1998; 5(5):1195-8. PubMed ID: 9683834
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of ras oncogenes in CIN III and in stage I and II invasive squamous cell carcinoma of the uterine cervix.
O'Leary JJ; Landers RJ; Silva I; Uhlmann V; Crowley M; Healy I; Luttich K
J Clin Pathol; 1998 Aug; 51(8):576-82. PubMed ID: 9828814
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of HPV18 in correlation with ras gene mutations and clinicopathological parameters in cervical cancer studied from stained cytological smears.
Dokianakis DN; Papaefthimiou M; Tsiveleka A; Spandidos DA
Oncol Rep; 1999; 6(6):1327-31. PubMed ID: 10523706
[TBL] [Abstract][Full Text] [Related]
4. K-ras mutations and HPV infection in cervicitis and intraepithelial neoplasias of the cervix.
Prokopakis P; Sourvinos G; Koumantaki Y; Koumantakis E; Spandidos DA
Oncol Rep; 2002; 9(1):129-33. PubMed ID: 11748470
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional activation of H- and N-ras oncogenes in human cervical cancer.
Mammas IN; Zafiropoulos A; Koumantakis E; Sifakis S; Spandidos DA
Gynecol Oncol; 2004 Mar; 92(3):941-8. PubMed ID: 14984964
[TBL] [Abstract][Full Text] [Related]
6. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
[TBL] [Abstract][Full Text] [Related]
7. Association between activated K-ras and c-erbB-2 oncogenes with "high-risk" and "low-risk" human papilloma virus types in preinvasive cervical lesions.
Mourón SA; Abba MC; Güerci A; Gómez MA; Dulout FN; Golijow CD
Mutat Res; 2000 Aug; 469(1):127-34. PubMed ID: 10946249
[TBL] [Abstract][Full Text] [Related]
8. Absence of point mutation in codons 12 and 13 of K-RAS oncogene in HPV-associated high grade dysplasia and squamous cell cervical carcinoma.
Pochylski T; Kwaśniewska A
Eur J Obstet Gynecol Reprod Biol; 2003 Nov; 111(1):68-73. PubMed ID: 14557015
[TBL] [Abstract][Full Text] [Related]
9. Uneven distribution of HPV 16 E6 prototype and variant (L83V) oncoprotein in cervical neoplastic lesions.
Andersson S; Alemi M; Rylander E; Strand A; Larsson B; Sällström J; Wilander E
Br J Cancer; 2000 Aug; 83(3):307-10. PubMed ID: 10917543
[TBL] [Abstract][Full Text] [Related]
10. Ha-ras oncogene mutation associated to progression of papillomavirus induced lesions of uterine cervix.
Alonio LV; Picconi MA; Dalbert D; Mural J; Bartt O; Bazán G; Dominguez M; Teyssié AR
J Clin Virol; 2003 Aug; 27(3):263-9. PubMed ID: 12878090
[TBL] [Abstract][Full Text] [Related]
11. Detection of human papillomavirus 16 transcriptional activity in cervical intraepithelial neoplasia grade III lesions and cervical carcinomas by nested reverse transcription-polymerase chain reaction and in situ hybridization.
Selinka HC; Sotlar K; Klingel K; Sauter M; Kandolf R; Bültmann B
Lab Invest; 1998 Jan; 78(1):9-18. PubMed ID: 9461118
[TBL] [Abstract][Full Text] [Related]
12. [Ha-ras and p53 gene mutations scanned by PCR-SSCP in premalignant and malignant lesions of the uterine cervix associated with human papillomavirus].
Alonio LV; Dalbert D; Picconi MA; Cervantes Vazquez G; García Carrancá A; Distefano AL; Mural J; Bartt O; Bazan G; Teyssie AR
Medicina (B Aires); 2000; 60(6):895-901. PubMed ID: 11436698
[TBL] [Abstract][Full Text] [Related]
13. p53 mutations in cervical carcinogenesis--low frequency and lack of correlation with human papillomavirus status.
Busby-Earle RM; Steel CM; Williams AR; Cohen B; Bird CC
Br J Cancer; 1994 Apr; 69(4):732-7. PubMed ID: 8142262
[TBL] [Abstract][Full Text] [Related]
14. Pre-vaccination epidemiology of human papillomavirus infections in Japanese women with abnormal cytology.
Yamasaki K; Miura K; Shimada T; Ikemoto R; Miura S; Murakami M; Sameshima T; Fujishita A; Kotera K; Kinoshita A; Yoshiura K; Masuzaki H
J Obstet Gynaecol Res; 2011 Nov; 37(11):1666-70. PubMed ID: 21793993
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer.
Huang TH; Lai HC; Liu HW; Lin CJ; Wang KH; Ding DC; Chu TY
Int J Gynecol Cancer; 2010 May; 20(4):513-9. PubMed ID: 20442585
[TBL] [Abstract][Full Text] [Related]
16. Distribution of human papilloma virus infections of uterine cervix among women of reproductive age--a cross sectional hospital-based study from North East India.
Sarma U; Mahanta J; Borkakoty B; Sarmah B
Asian Pac J Cancer Prev; 2015; 16(4):1519-23. PubMed ID: 25743824
[TBL] [Abstract][Full Text] [Related]
17. Indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase expression in HPV infection, SILs, and cervical cancer.
Venancio PA; Consolaro MEL; Derchain SF; Boccardo E; Villa LL; Maria-Engler SS; Campa A; Discacciati MG
Cancer Cytopathol; 2019 Sep; 127(9):586-597. PubMed ID: 31412167
[TBL] [Abstract][Full Text] [Related]
18. Induction of p16 during immortalization by HPV 16 and 18 and not during malignant transformation.
Nakao Y; Yang X; Yokoyama M; Ferenczy A; Tang SC; Pater MM; Pater A
Br J Cancer; 1997; 75(10):1410-6. PubMed ID: 9166931
[TBL] [Abstract][Full Text] [Related]
19. DNA aneuploidy and integration of human papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri.
Melsheimer P; Vinokurova S; Wentzensen N; Bastert G; von Knebel Doeberitz M
Clin Cancer Res; 2004 May; 10(9):3059-63. PubMed ID: 15131043
[TBL] [Abstract][Full Text] [Related]
20. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.
Hudelist G; Manavi M; Pischinger KI; Watkins-Riedel T; Singer CF; Kubista E; Czerwenka KF
Gynecol Oncol; 2004 Mar; 92(3):873-80. PubMed ID: 14984955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
